Navigation Links
Photos: New Survey Shows Many Successful Quit Smoking Attempts Made Without Advance Planning

Survey found spontaneous quit attempts can be successful

PITTSBURGH, Sept. 24 /PRNewswire/ -- For some smokers, carefully planning a quit attempt may not be the path to becoming smoke-free. While there are benefits to preparing yourself for a quit attempt, a new national survey conducted by Nicorette Cinnamon Surge shows that for some, successfully quitting may not require an advance plan.(1) In fact, half (49 percent) of successful quitters surveyed reported that their most recent quit attempt started without any advance planning.(2)

To view the Multimedia News Release, go to:

"Some behavioral science experts have long thought of spontaneity as a relatively risky trait, often leading to negative actions and outcomes," said Frank Vitale, national director, Pharmacy Partnership for Tobacco Cessation and GlaxoSmithKline (GSK) Consumer Healthcare spokesperson. "What is interesting about this survey is that it found that acting spontaneously can lead people to make a healthy lifestyle change they may have otherwise delayed."

Modeled after a recent study of UK smokers conducted by Robert West and Taj Sohal at University College London and published in the British Medical Journal, the U.S. survey findings show that spontaneous attempts can be successful and are occurring frequently.(3)

"These new survey results, show a pattern similar to what our study found pertaining to the way smokers seem very able to translate a decision to quit immediately in to action," said Robert West, Professor of Health Psychology and Director of Tobacco Studies at the Cancer Research UK Health Behavior Unit. "Tensions build within a smoker during certain events, such as a recent health concern, or a new increase in the cost of cigarettes. Eventually, even a small trigger can lead to a sudden and dramatic change in perception, ultimately causing the individual to feel a need to stop smoking immediately."(4)

While the survey found that some smokers find a spontaneous quit can be effective(5), experts agree that finding an approach that is right for the individual, including the use of proven smoking cessation methods is the best plan for long-term success.

"Any attempt to quit smoking is a positive step in the right direction; the right method depends on each smokers individual needs," said Frank Vitale, national director, Pharmacy Partnership for Tobacco Cessation and GSK spokesperson. "These survey findings don't necessarily imply that planning quit attempts would be counterproductive or that smokers should quit without any assistance. Even spontaneous quitters can improve their chances significantly by developing a plan to deal with tough situations and cravings and by taking advantage of proven stop smoking tools such as Nicorette Cinnamon Surge gum."

Nicotine replacement therapy such as new Nicorette Cinnamon Surge is readily available over the counter without a doctor's prescription at more than 35,000 retail outlets, and can help reduce withdrawal symptoms commonly associated with quitting smoking(6). GlaxoSmithKline Consumer Healthcare is now offering smokers who want to quit a free 20 piece starter pack of new Nicorette Cinnamon Surge, while supplies last. Interested consumers can dial 1-800-Nicorette or visit to request their starter pack and also access free smoking cessation counseling available as part of the offer.

"Recognizing that every smoker is different, we developed new Nicorette Cinnamon Surge for smokers that prefer the bold taste of cinnamon," said Bill Slivka, Vice President, GlaxoSmithKline Smoking Control. "Now with new Nicorette Cinnamon Surge, and our free starter pack offer, these smokers can act on their spontaneity by giving quitting a try."

About Nicorette

Nicorette is a stop-smoking aid which provides fast, safe, controlled doses of nicotine to ease withdrawal from cigarettes. Convenient to carry and use, Nicorette allows smokers to control how much nicotine they use, and gives them the added flexibility of chewing an additional piece within the hour to treat strong or frequent cravings. Nicorette is sugar-free and available in strengths of 2mg (for smokers of less than 25 cigarettes each day) and 4mg (for smokers of 25 or more cigarettes each day) and also is available in exciting flavors such as Fresh Mint, Fruit Chill and new Cinnamon Surge.


GlaxoSmithKline Consumer Healthcare is one of the world's largest over- the-counter consumer healthcare products companies. Its more than 30 well- known brands include the products Nicorette, NicoDerm CQ, Commit, Abreva, Aquafresh, Sensodyne, and Tums, trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies. About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and consumer healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

A survey of 1,700 respondents (900 adults age 18 and over who currently smoke cigarettes every day and 800 adults, age 18 and over, who previously smoked every day but quit between one month and ten years ago) in the U.S. was fielded in July 2007 by Richard Day Research through an online panel, screening for adults age 18 and over. The data was weighted to adjust for the age, ethnicity and gender using estimates from the 2006 National Health Interview Survey.

(1)Survey of adult smokers and ex-smokers conducted by GlaxoSmithKline

Consumer Healthcare in July 2007.

(2)Survey of adult smokers and ex-smokers conducted by GlaxoSmithKline

Consumer Healthcare in July 2007.

(3)Survey of adult smokers and ex-smokers conducted by GlaxoSmithKline

Consumer Healthcare in July 2007.

(4)West, Robert (2006) "Catastrophic" pathways to smoking cessation:

findings from a national survey; British Medical Journal, 332; 458-460

(5)Survey of adult smokers and ex-smokers conducted by GlaxoSmithKline

Consumer Healthcare in July 2007.



Jennifer May Mark Polisky

GlaxoSmithKline Consumer Healthcare GolinHarris

412.200.3729 312.729.4417

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Eating disorder... a survey
2. Happiness Survey
3. Survey shows how bipolar disorder affects the quality of life for patients
4. Over Six Million HIV Infected People In South Africa- Finds A Survey
5. Rural India shows apathy towards dental problems: Survey
6. Survey finds that discussion with family very crucial in organ donation decision
7. Insomnia Hits Many Canadians: Survey
8. Scotland Ranked As Sickest Area Of UK: Survey
9. Americans Not Interested In Choosing Sex Of Child: Survey
10. A National Survey Revealed That Mental Disorders Are Common In Lebanon
11. Ignorance about AIDS rampart in Third of College Students: Chinese survey
Post Your Comments:
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... On November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction ... , “We wake up every day excited to rebuild lives and it’s an honor ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact ... and reliability. , The new Q-Suite 6 platform is based on the latest Java ... into a specific piece of software for many key components of the suite. Much ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
Breaking Medicine Technology: